采用移植后大剂量环磷酰胺的单倍型相合造血干细胞移植治疗获得性重型再生障碍性贫血 - Suppr

Suppr

超能文献

Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY.

作者信息

Gupta N, Choudhary D, Sharma S K, Khandelwal V, Dhamija M

机构信息

Department of Hematooncology and Bone Marrow Transplant, BLK Super Specialty Hospital, New Delhi, India.

出版信息

Bone Marrow Transplant. 2015 Jan;50(1):155-6. doi: 10.1038/bmt.2014.222. Epub 2014 Oct 6.

DOI:10.1038/bmt.2014.222

PMID:25285802

Abstract

摘要

相似文献

Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY.采用移植后大剂量环磷酰胺的单倍型相合造血干细胞移植治疗获得性重型再生障碍性贫血

Bone Marrow Transplant. 2015 Jan;50(1):155-6. doi: 10.1038/bmt.2014.222. Epub 2014 Oct 6.

[Treatment strategy for acquired aplastic anemia].

Rinsho Ketsueki. 2018;59(10):1969-1978. doi: 10.11406/rinketsu.59.1969.

Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.单倍体相合骨髓移植及移植后环磷酰胺治疗重型再生障碍性贫血：一项多中心回顾性研究

Bone Marrow Transplant. 2015 May;50(5):685-9. doi: 10.1038/bmt.2015.20. Epub 2015 Mar 2.

Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.再生障碍性贫血的异基因造血干细胞移植：当前的适应证及移植策略

Blood Rev. 2021 May;47:100772. doi: 10.1016/j.blre.2020.100772. Epub 2020 Oct 31.

[Treatment of aplastic anemia in children].[儿童再生障碍性贫血的治疗]

Rinsho Ketsueki. 2014 Oct;55(10):1769-76.

[Treatment of acquired a plastic anemia: an update].[获得性再生障碍性贫血的治疗：最新进展]

Rinsho Ketsueki. 2004 Mar;45(3):202-8.

[Hematopoietic stem cell transplantation for acquired aplastic anemia].

Rinsho Ketsueki. 2015 Oct;56(10):2153-9. doi: 10.11406/rinketsu.56.2153.

Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.单倍体相合造血干细胞移植作为挽救疗法治疗儿童和青少年获得性重度再生障碍性贫血的良好疗效。

Bone Marrow Transplant. 2014 Dec;49(12):1481-5. doi: 10.1038/bmt.2014.187. Epub 2014 Aug 18.

Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.

Biol Blood Marrow Transplant. 2005 Jul;11(7):567-8. doi: 10.1016/j.bbmt.2005.03.004.

Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.基于氟达拉滨的预处理方案在接受亲缘相合供者移植的高危再生障碍性贫血患者中的疗效：来自巴基斯坦的单中心研究。

Biol Blood Marrow Transplant. 2019 Dec;25(12):2375-2382. doi: 10.1016/j.bbmt.2019.07.029. Epub 2019 Aug 5.

引用本文的文献

Idiopathic Aplastic anemia: Indian Perspective.特发性再生障碍性贫血：印度视角

Indian J Hematol Blood Transfus. 2023 Jul;39(3):357-370. doi: 10.1007/s12288-022-01592-4. Epub 2022 Oct 31.

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties.同种异体造血干细胞移植治疗自身免疫性疾病：来自 EBMT 自身免疫性疾病工作组、免疫效应细胞工作组和移植后疾病工作组的回顾性研究。

Front Immunol. 2019 Jul 4;10:1570. doi: 10.3389/fimmu.2019.01570. eCollection 2019.

Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.单倍体相合供者骨髓移植治疗重型再生障碍性贫血

Hematol Oncol Clin North Am. 2018 Aug;32(4):629-642. doi: 10.1016/j.hoc.2018.04.001. Epub 2018 May 28.

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.严重再生障碍性贫血患者采用单倍体相合造血干细胞联合人脐带间充质干细胞治疗的临床评价。

Eur J Med Res. 2018 Mar 1;23(1):12. doi: 10.1186/s40001-018-0311-3.

Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.重型再生障碍性贫血中不断发展的造血干细胞移植策略

Curr Opin Pediatr. 2016 Feb;28(1):3-11. doi: 10.1097/MOP.0000000000000299.

Unmanipulated haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in a patient with paroxysmal nocturnal hemoglobinuria and secondary aplastic anemia.在一名阵发性夜间血红蛋白尿症和继发性再生障碍性贫血患者中进行未处理的单倍体相合造血细胞移植并联合移植后环磷酰胺治疗

Bone Marrow Transplant. 2016 Feb;51(2):316-8. doi: 10.1038/bmt.2015.251. Epub 2015 Oct 26.

Bone Marrow Transplant. 2015 May;50(5):685-9. doi: 10.1038/bmt.2015.20. Epub 2015 Mar 2.

本文引用的文献

Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.低强度预处理后，来自相关单倍体相合供者的外周血造血干细胞用于血液系统疾病的移植

Biol Blood Marrow Transplant. 2014 Jun;20(6):890-5. doi: 10.1016/j.bbmt.2014.03.003. Epub 2014 Mar 18.

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.非清髓性预处理方案及移植后环磷酰胺用于单倍体相合移植时骨髓与外周血干细胞的比较

Biol Blood Marrow Transplant. 2014 May;20(5):724-9. doi: 10.1016/j.bbmt.2014.02.001. Epub 2014 Feb 13.

Management of the refractory aplastic anemia patient: what are the options?再生障碍性贫血患者的治疗管理：有哪些选择？

Blood. 2013 Nov 21;122(22):3561-7. doi: 10.1182/blood-2013-05-498279. Epub 2013 Sep 19.

Haploidentical transplantation in patients with acquired aplastic anemia.获得性再生障碍性贫血患者的单倍体相合移植。

Bone Marrow Transplant. 2013 Feb;48(2):183-5. doi: 10.1038/bmt.2012.231. Epub 2013 Jan 7.

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.HLA 单倍体相合骨髓移植联合移植后环磷酰胺可扩大镰状细胞病患者的供者池。

Blood. 2012 Nov 22;120(22):4285-91. doi: 10.1182/blood-2012-07-438408. Epub 2012 Sep 6.

Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts.采用 T 细胞富含的骨髓移植物进行人类白细胞抗原单倍体相合干细胞移植。

Curr Opin Hematol. 2012 Nov;19(6):440-7. doi: 10.1097/MOH.0b013e32835822dc.

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.氟达拉滨、环磷酰胺、抗胸腺细胞球蛋白联合或不联合低剂量全身照射，用于异基因供者移植治疗获得性重型再生障碍性贫血：来自 EBMT-SAA 工作组的回顾性研究。

Haematologica. 2010 Jun;95(6):976-82. doi: 10.3324/haematol.2009.018267. Epub 2010 May 21.

Acquired aplastic anemia in childhood.儿童获得性再生障碍性贫血。

Hematol Oncol Clin North Am. 2009 Apr;23(2):171-91. doi: 10.1016/j.hoc.2009.01.011.

Biol Blood Marrow Transplant. 2008 Sep;14(9):1057-1063. doi: 10.1016/j.bbmt.2008.07.003.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.采用非清髓性预处理及大剂量移植后环磷酰胺的HLA单倍型相合骨髓移植治疗血液系统恶性肿瘤

Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50. doi: 10.1016/j.bbmt.2008.03.005.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验